DeepMed Research

QUEEN MARY UNIVERSITY OF LONDON

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1882-01-08

Employees: 1K

Market Cap: -

Website: http://www.qmul.ac.uk

Clinical Trials

Fostering Inmates' Well-being and Mental Health

Not Applicable

Terminated

Conditions: Well-being

Interventions: Other: Transcendental Meditation training

First Posted Date: 2021-02-10

Last Posted Date: 2022-01-25

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 44

Registration Number: NCT04747730

Locations: 🇬🇧
HMP Warren Hill, Woodbridge, United Kingdom

Efficacy of Mouthwashes in Reducing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Saliva

Not Applicable

Completed

Conditions: Covid19
Coronavirus

Interventions: Drug: Corsodyl® Alcohol free -0.2 % Chlorhexidine digluconate
Other: Oral-B® Gum & Enamel Care -Cetylpyridinium chloride
Drug: Colgate Peroxyl® -1.5% Hydrogen peroxide
Other: No rinsing

First Posted Date: 2021-01-25

Last Posted Date: 2023-09-14

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 54

Registration Number: NCT04723446

Locations: 🇬🇧
Newham Hospital, London, United Kingdom
🇬🇧
Royal London Hospital, London, United Kingdom

Genetic Variants and Regulation of Specialized Pro-resolving Mediator

Recruiting

Conditions: Inflammatory Disease
Cardiovascular Diseases
Healthy

Interventions: Procedure: Blood Donation

First Posted Date: 2021-01-06

Last Posted Date: 2024-12-02

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 200

Registration Number: NCT04698291

Locations: 🇬🇧
Queen Mary University of London, London, United Kingdom

Children's Health in London and Luton (CHILL)

Active, not recruiting

Conditions: Child Development
Pollution; Exposure
Respiratory Disease

Interventions: Other: Ultra Low Emission Zone (ULEZ)

First Posted Date: 2021-01-05

Last Posted Date: 2025-03-10

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 3312

Registration Number: NCT04695093

Locations: 🇬🇧
Queen Mary University of London, London, United Kingdom

ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis

Phase 2

Recruiting

Conditions: Progressive Multiple Sclerosis
Advanced Multiple Sclerosis

Interventions: Drug: Cladribine (MAVENCLAD®)
Drug: Placebo

First Posted Date: 2021-01-05

Last Posted Date: 2025-03-10

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 200

Registration Number: NCT04695080

Locations: 🇬🇧
Morriston Hospital, Swansea, Swansea, United Kingdom
🇬🇧
Luton and Dunstable Hospital, Luton, United Kingdom
🇬🇧
Salford Royal Hospital NHS Trust, Manchester, United Kingdom

and more 19 locations

Identification of Autoantigens in EGPA and Severe Eosinophilic Asthma

Completed

Conditions: Eosinophilic Esophagitis
Eosinophilic Asthma
Churg-Strauss Syndrome
Eosinophilic Pneumonia

Interventions: Diagnostic Test: Autoantibody ELISA

First Posted Date: 2020-12-17

Last Posted Date: 2025-03-25

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 120

Registration Number: NCT04671446

Locations: 🇬🇧
Barts Health NHS Trust, Dept of Rheumatology, Mile End Hospital, London, United Kingdom
🇬🇧
Barts Health NHS Trust, Dept of Respiratory Medicine, St Bartholomew's Hospital, London, United Kingdom

Neoadjuvant Immune Checkpoint Inhibitor Treatment in Urothelial Cancer

Phase 2

Recruiting

Conditions: Urogenital Cancer

Interventions: Drug: Atezolizumab

First Posted Date: 2020-11-10

Last Posted Date: 2024-11-04

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 58

Registration Number: NCT04624399

Locations: 🇬🇧
Barts and London Hospital NHS Trust, London, United Kingdom

Trial of Vitamin D to Reduce Risk and Severity of COVID-19 and Other Acute Respiratory Infections

Phase 3

Completed

Conditions: Acute Respiratory Tract Infection
Covid19

Interventions: Dietary Supplement: Vitamin D

First Posted Date: 2020-10-08

Last Posted Date: 2022-04-06

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 6200

Registration Number: NCT04579640

Locations: 🇬🇧
Queen Mary University of London, London, County (optional), United Kingdom

Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension

Phase 4

Completed

Conditions: Hypertension

Interventions: Drug: Amlodipine

First Posted Date: 2020-09-22

Last Posted Date: 2024-02-13

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 343

Registration Number: NCT04559074

Locations: 🇬🇧
William Harvey Research Institute Clinical Research Centre, Queen Mary University of London, London, London - City Of London, United Kingdom
🇬🇧
Queen Mary University London, London, United Kingdom

Cardiac and Immune Cell Function in Preeclampsia

Completed

Conditions: Hypertension
Cardiovascular Diseases
Cardiovascular Risk Factor
Heart Diseases
Preeclampsia
Pregnancy Induced Hypertension
Pregnancy Related

Interventions: Diagnostic Test: Cardiovascular magnetic resonance
Diagnostic Test: Echocardiography
Diagnostic Test: Blood test

First Posted Date: 2020-08-11

Last Posted Date: 2025-03-10

Lead Sponsor: Queen Mary University of London

Target Recruit Count: 86

Registration Number: NCT04508582

Locations: 🇬🇧
Barts Health NHS Trust, The Royal London Hospital, London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy